Guggenheim Downgrades 2seventy bio to Neutral
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Kelsey Goodwin has downgraded 2seventy bio (NASDAQ:TSVT) from Buy to Neutral.

September 12, 2023 | 7:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
2seventy bio has been downgraded from Buy to Neutral by Guggenheim.
The downgrade from Buy to Neutral by Guggenheim analyst Kelsey Goodwin indicates a less optimistic outlook for the company's stock in the short term. This could potentially lead to a decrease in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100